Breast tumor cells that lack the expression of human epidermal growth factor receptor 2 (HER2), the progesterone receptor (PR), and the estrogen receptor (ER) define a subgroup of breast cancer as triple-negative breast cancer (TNBC) [4]. This evidence concerns the gene ERBB2 and breast neoplasm.